RegStem is a cutting-edge biotechnology and biopharmaceutical company based in Paris, France, at the Paris Biotech life science incubator. The company specializes in the field of regenerative medicine, focusing on the development and repurposing of drugs that aid in the repair and regeneration of human tissues. Specifically, RegStem is working on innovative molecules that can stimulate stem cells to reconstitute and repair bone marrow during acute aplasia (a condition where the bone marrow stops producing blood cells) and improve skin healing after scarring.

RegStem's primary clients are pharmaceutical companies that are interested in licensing new, clinically tested drugs. The company operates in the highly specialized and rapidly growing market of regenerative medicine, which involves treatments that help the body repair, replace, or regenerate damaged tissues and organs.

The business model of RegStem revolves around research and development (R&D) and licensing. The company invests in the discovery and development of new therapeutic molecules. Once these molecules have been tested and proven effective through clinical trials, RegStem licenses them to larger pharmaceutical companies. This licensing model allows RegStem to generate revenue without the need to manufacture and distribute the drugs themselves.

In addition to its core business activities, RegStem is committed to fostering new talent in the fields of science and business. The company offers internships to qualified students, providing them with hands-on experience in the biotechnology and pharmaceutical industries.

In summary, RegStem is a pioneering company in the regenerative medicine sector, focusing on creating and repurposing drugs that stimulate stem cells for tissue repair. It serves pharmaceutical companies by providing them with innovative, clinically tested molecules for licensing. The company makes money through its R&D efforts and subsequent licensing agreements.

Keywords: Regenerative medicine, biotechnology, biopharmaceutical, stem cells, drug development, licensing, clinical trials, tissue repair, pharmaceutical clients, Paris Biotech.